SOVAPE Disbands: Impact on the E-Cigarette Community

Oct.10.2024
SOVAPE Disbands: Impact on the E-Cigarette Community
French e-cigarette organization SOVAPE announced its dissolution after facing allegations of ties to the tobacco industry.

According to a recent report by Vaping 360, the French e-cigarette organization SOVAPE announced this week that it will be dissolving.


It is reported that SOVAPE has been active in the e-cigarette industry since 2016, gaining recognition for hosting three editions of the French e-cigarette summit from 2016 to 2019. The organization is also a co-founder of the European Tobacco Harm Reduction Advocates (ETHRA) alliance.


Since 2019, SOVAPE has commissioned the well-known market research company BVA to survey the French public's opinion on e-cigarettes and nicotine. However, this year (2024), BVA informed SOVAPE that due to a contract with a health industry client prohibiting BVA from collaborating with organizations associated with nicotine, BVA will no longer be involved.


The sudden cancellation of this survey, coupled with recent news reports accusing SOVAPE and other consumer organizations of being linked to the tobacco industry, has led to attacks on scientists and health professionals supporting SOVAPE. On October 6, SOVAPE announced on its official website that "the review, threats, lies, defamation, as well as the spread of fake news and denial of scientific data have created an atmosphere that makes it impossible to sustain this mission." The association announced its dissolution.


SOVAPE has decided to donate its remaining funds to the Pasteur Institute, as well as other e-cigarette organizations AIDUCE and La Vape du Cœur. In addition, SOVAPE has covered the costs to ensure its website remains available for the next 10 years, and has preserved the relevant videos of e-cigarette summit on its YouTube channel.


We regret that we can no longer continue the dialogue to promote methods that reduce the risk of disease prevention and premature death. We do not regret trying, but we must acknowledge that we can no longer continue this crucial fight for us. However, our efforts have already made a contribution to saving lives!


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Canada’s B.C. Passes First Vaping Cost-Recovery Framework, Allowing Government to Sue Manufacturers Over Health Expenses
Canada’s B.C. Passes First Vaping Cost-Recovery Framework, Allowing Government to Sue Manufacturers Over Health Expenses
According to the Nelson Star, British Columbia has passed the Vaping Product Damages and Health Care Costs Recovery Act by a 49–42 vote. The legislation enables the provincial government to seek recovery of future public health costs from vape manufacturers, following models used in opioid and tobacco litigation.
Dec.03
Japan Tobacco Announces Executive Leadership Changes Effective in 2026
Japan Tobacco Announces Executive Leadership Changes Effective in 2026
Japan Tobacco Inc. (JT) has announced a series of executive and board appointments effective from 2026, including the nomination of Takehiko Tsutsui—currently Executive Vice President at JT International—as President, CEO and Representative Director.
Nov.26
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned
Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.
Nov.06 by 2FIRSTS.ai
Ukraine intensifies crackdown on illicit tobacco and alcohol markets
Ukraine intensifies crackdown on illicit tobacco and alcohol markets
Ukraine’s State Tax Service (GNS) has carried out around 24,000 on-site inspections in the tobacco and alcohol sectors this year, imposing more than ₴795 million (US$194 million) in fines and revoking over 2,500 business licences.
Oct.17 by 2FIRSTS.ai
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
British American Tobacco has paused the U.S. pilot launch of its unlicensed Vuse One vape amid intensified FDA enforcement.
Oct.28 by 2FIRSTS.ai
Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute
Ohio Appeals Court Rejects State Attorney General's Lawsuit Against E-Cigarette Retailer, Emphasizing FDA Regulatory Authority.
Oct.15 by 2FIRSTS.ai